Workflow Intelligence

Workflow Intelligence-PV^TM

Workflow Intelligence-PV^TM mitigates operational risk enabling companies to optimize Adverse Event (AE) case processing through the application of modeling and simulation to better align limited resources to high risk areas, identify opportunities to reduce costs, rapidly respond to fluctuations in AE case load, and improve capacity and compliance. Our proprietary template-based AE process model development and simulation environment provides a safety analyst with the ability to examine alternative scenarios through simulations as well as implement business activity monitoring with customizable executive dashboards.

Case Handling
Case handling is subjected to variations in the way AEs are received and processed. These variations can come from the following circumstances:

	Volume fluctuations due to the addition of new drugs or company acquisitions
	Volume fluctuations caused by seasonal usage of drugs
	Process activity time variations due to the type of AE (new, expected, serious and non-serious) and the level of follow-up

Benefits of Case Handling Simulation

Workflow Intelligence-PV's case handling simulation provides clear insight into your system dynamics:

Capacity:
What is the throughput capacity of the system?

Workload:
Should workload or activities be performed at a single site or distributed?

Technology:
What is the effect of using automation?

Optimization:
What is the optimum number of resources?

Resource Scheduling:
What personnel and equipment are needed on which shift?

Workflow Intelligence-PV uses a proactive, optimized resource strategy that will ensure on-time regulatory report submission while maximizing the use of skilled resources with minimum cost.

How Patni Can Help
Patni's comprehensive set of drug safety products and services, Intelligent Solutions-PV^TM, can help you improve processes, procedures, signaling capabilities, documentation and proactive monitoring. Compliance with Good Pharmacovigilance Practices is essential for a company to demonstrate it has followed the appropriate procedures during development and post-marketing in order to protect patient safety. Patni remains committed to helping our clients bring new products to market and to protect our clients' existing products.